Response to Morfeld (2013): Second commentary to Gebel 2012—established use of cancer potency indices and biological plausibility

Author： Gebel Tom  

Publisher： Springer Publishing Company

ISSN： 0340-5761

Source： Archives of Toxicology, Vol.87, Iss.11, 2013-11, pp. : 2027-2029

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Commentary to Gebel 2012: A quantitative review should apply meta-analytical methods—and this applies also to quantitative toxicological reviews

By Morfeld Peter  

Archives of Toxicology, Vol. 87, Iss. 11, 2013-11 ,pp. : 2023-2025

Springer Publishing Company

Access to resources Recommend Favorite

Response to Commentary

By  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 4, 2008-07 ,pp. : 644-645

Taylor & Francis Ltd

Access to resources Recommend Favorite

Testing Therapeutic Potency of Anticancer Drugs in Animal Studies: A Commentary

By den Otter W.   Steerenberg P.A.   van der Laan J.W.  

Regulatory Toxicology and Pharmacology, Vol. 35, Iss. 2, 2002-04 ,pp. : 266-272

Academic Press

Access to resources Recommend Favorite

Apoptotic Potency of Angiostatic Compounds in the Treatment of Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 11, 2012-09 ,pp. : 2283-2289

Bentham Science Publishers

Access to resources Recommend Favorite

The assessment of antagonist potency under conditions of transient response kinetics

By Christopoulos A.   Parsons A.M.   Lew M.J.   El-Fakahany E.E.  

European Journal of Pharmacology, Vol. 382, Iss. 3, 1999-10 ,pp. : 217-227

Elsevier

Access to resources Recommend Favorite